AMF Tjanstepension AB Invests $2.87 Million in Intuitive Surgical, Inc. (NASDAQ:ISRG)

AMF Tjanstepension AB purchased a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 5,505 shares of the medical equipment provider’s stock, valued at approximately $2,873,000.

Several other institutional investors have also modified their holdings of ISRG. Massachusetts Financial Services Co. MA purchased a new position in shares of Intuitive Surgical during the 3rd quarter worth $558,807,000. Proficio Capital Partners LLC raised its holdings in shares of Intuitive Surgical by 89,098.8% during the 4th quarter. Proficio Capital Partners LLC now owns 949,967 shares of the medical equipment provider’s stock worth $495,845,000 after acquiring an additional 948,902 shares during the period. FMR LLC raised its holdings in Intuitive Surgical by 8.3% in the 3rd quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock valued at $5,389,765,000 after buying an additional 838,793 shares during the period. Raymond James Financial Inc. purchased a new stake in Intuitive Surgical in the 4th quarter valued at about $313,769,000. Finally, Wilmington Savings Fund Society FSB raised its holdings in Intuitive Surgical by 15,322.2% in the 3rd quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider’s stock valued at $272,980,000 after buying an additional 552,058 shares during the period. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Performance

Shares of Intuitive Surgical stock opened at $518.26 on Friday. Intuitive Surgical, Inc. has a one year low of $364.17 and a one year high of $616.00. The company has a market cap of $184.59 billion, a PE ratio of 80.85, a P/E/G ratio of 5.85 and a beta of 1.43. The business has a 50-day simple moving average of $571.36 and a 200-day simple moving average of $531.53.

Analysts Set New Price Targets

Several analysts recently issued reports on the stock. Wells Fargo & Company boosted their price objective on shares of Intuitive Surgical from $630.00 to $687.00 and gave the company an “overweight” rating in a report on Friday, January 24th. Erste Group Bank upgraded shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Tuesday, November 19th. Citigroup boosted their price objective on shares of Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a report on Friday, January 24th. Royal Bank of Canada boosted their price objective on shares of Intuitive Surgical from $611.00 to $641.00 in a report on Monday, January 27th. Finally, CICC Research assumed coverage on shares of Intuitive Surgical in a report on Monday, January 27th. They issued a “neutral” rating and a $550.00 price objective on the stock. One analyst has rated the stock with a sell rating, four have assigned a hold rating and sixteen have given a buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $613.10.

Insider Transactions at Intuitive Surgical

In related news, SVP Mark Brosius sold 489 shares of the company’s stock in a transaction that occurred on Friday, March 7th. The stock was sold at an average price of $533.18, for a total value of $260,725.02. Following the completion of the transaction, the senior vice president now directly owns 2,091 shares of the company’s stock, valued at $1,114,879.38. This represents a 18.95 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CFO Jamie Samath sold 270 shares of the company’s stock in a transaction that occurred on Tuesday, December 10th. The shares were sold at an average price of $540.15, for a total value of $145,840.50. Following the completion of the transaction, the chief financial officer now directly owns 8,757 shares of the company’s stock, valued at $4,730,093.55. This trade represents a 2.99 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 13,579 shares of company stock valued at $7,756,844. 0.90% of the stock is currently owned by corporate insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.